IDH1 and central nervous system cancer: The pooled OR for IDH1 mutation in the CIMP + versus CIMP- glioma revealed a significantly higher risk of IDH1 mutation in the CIMP + glioma (OR 229.07; 95% CI 138.72–378.26; P < .00001, Pheterogeneity 0.000).